Studienlage · Detail
Schaden
GRADE
Niedrig
24 Zitate
Stichproben = 43.466 Pat.
DauerQuerschnittsdaten aus 2002 und…
KontrolleKein oder seltener Cannabiskonsum
EndpunktSuizidideen / MDE
Verblindungn.a.
DesignKohortenstudie
Kernaussage
Monatliche Cannabisnutzung war mit erhöhten Odds für Suizidgedanken (OR 1,59) und depressive Episode (OR 1,55) assoziiert; Assoziation verstärkte sich von 2002 zu 2012.
Zusammenfassung
Gepoolte Querschnittsdaten aus Canadian Community Health Survey 2002 und 2012 (n=43.466, Alter 15-60 Jahre). Mindestens monatlicher Cannabis-Konsum assoziiert mit erhöhter Odds für Major Depressive Episode (MDE) und Suizidgedanken. Assoziation verstärkte sich 2012 vs. 2002: OR=1.59 (95% CI 1.11-2.27) für Suizidgedanken, OR=1.55 (95% CI 1.12-2.13) für MDE. Effekt persistierte nach Kontrolle für anderen Substanzkonsum.
P
PopulationKanadische Erwachsene (15–60 Jahre) aus nationalen Querschnittsstichproben 2002 und 2012, n=43.466
I
InterventionMindestens monatlicher Nicht-medizinischer Cannabiskonsum
C
KontrolleKein oder seltener Cannabiskonsum
O
OutcomeMonatlicher Cannabiskonsum assoziiert mit erhöhten Odds für Suizidideen (OR 1,59; 95%-KI 1,11–2,27) und Major Depression (OR 1,55; 95%-KI 1,12–2,13) in 2012 vs. 2002
Vertrauen in die Evidenz
Niedrig
Zweite von vier GRADE-Stufen, die Effektschätzung ist begrenzt verlässlich.
Qualitätsprofil
Größe
★★★★★
Verblindung
—
Effektstärke
Schaden
Zitate / Jahr
★★★★★
Autoren
Teilen
Abstract
Background: With the recent legalization of nonmedical cannabis in Canada, it is important to document previous associations between cannabis use and major depressive episode and suicidal ideation, as well as the extent to which these associations have changed over time.
Methods: This study uses pooled data from the 2002 and 2012 Canadian Community Health Survey's Mental Health Component, which are repeated cross-sectional surveys of nationally representative samples of Canadians 15 to 60 years of age (n = 43,466). Binary logistic regression was performed, applying weighting and bootstrapping, to examine the association between at least monthly use of cannabis and past 12-month suicidal ideation and major depressive episode (MDE).
Results: At least monthly nonmedical cannabis use was associated with an increased odds of MDE and suicidal ideation, and both associations strengthened in 2012 compared to 2002. Canadians using cannabis at least once a month in 2012 had 1.59 (95% confidence interval [CI], 1.11 to 2.27) times the odds of experiencing suicidal ideation and 1.55 (95% CI, 1.12 to 2.13) times the odds of experiencing MDE compared to those who used cannabis at least once a month in 2002. This temporal change remained after controlling for other substance use.
Conclusions: Monthly cannabis use was consistently related to both suicidal ideation and MDE, and these associations were stronger in 2012 compared to 2002. The findings of this study provide a baseline for the association between cannabis use and suicide and depression in the Canadian population that should be reevaluated now that nonmedical cannabis has been legalized.
„Was dem Handeln im Weg steht, wird zum Weg.“